CONFALONIERI, PAOLA
 Distribuzione geografica
Continente #
EU - Europa 950
NA - Nord America 928
AS - Asia 566
AF - Africa 16
SA - Sud America 7
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.471
Nazione #
US - Stati Uniti d'America 919
IT - Italia 406
HK - Hong Kong 227
SE - Svezia 179
CN - Cina 145
SG - Singapore 87
DE - Germania 56
BG - Bulgaria 55
FI - Finlandia 45
IE - Irlanda 42
CH - Svizzera 34
GB - Regno Unito 29
KR - Corea 28
VN - Vietnam 25
IN - India 22
PL - Polonia 22
UA - Ucraina 18
FR - Francia 13
ES - Italia 11
SN - Senegal 10
BE - Belgio 9
NL - Olanda 7
JP - Giappone 6
RU - Federazione Russa 6
MX - Messico 5
TR - Turchia 5
TW - Taiwan 5
CZ - Repubblica Ceca 4
DK - Danimarca 4
EG - Egitto 4
IR - Iran 4
CO - Colombia 3
RO - Romania 3
SA - Arabia Saudita 3
YE - Yemen 3
AT - Austria 2
AU - Australia 2
BR - Brasile 2
CA - Canada 2
CL - Cile 2
PH - Filippine 2
PT - Portogallo 2
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
IL - Israele 1
KZ - Kazakistan 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PR - Porto Rico 1
Totale 2.471
Città #
Chandler 258
Hong Kong 220
Trieste 90
Ashburn 69
Princeton 56
Sofia 55
Beijing 54
Singapore 40
Boardman 37
Dublin 31
Milan 29
Redmond 29
Seoul 28
Wilmington 26
Bern 25
Dong Ket 25
Columbus 23
Helsinki 22
Lappeenranta 22
Warsaw 22
Rome 15
Bremen 14
Los Angeles 14
Ann Arbor 12
Woodbridge 12
Redwood City 11
Seattle 11
Shanghai 11
Dakar 10
Tappahannock 10
Turin 10
Boydton 9
Fairfield 9
Pune 9
Brussels 8
Grafing 8
Jacksonville 8
Manchester 7
Somerville 7
Treviso 7
Guangzhou 6
Menomonie 6
Udine 6
Washington 6
Birmingham 5
Duino-Aurisina 5
Padova 5
Saint Louis 5
Bari 4
Beregazzo con Figliaro 4
Calcinato 4
Central 4
Council Bluffs 4
Gurgaon 4
Moscow 4
Paris 4
Pescara 4
San Floriano del Collio 4
Tokyo 4
Tolmezzo 4
Verona 4
West Jordan 4
Capo d'Orlando 3
Cittadella 3
Gainesville 3
Genoa 3
Houston 3
Kochi 3
Liverpool 3
Madrid 3
Mantova 3
Nanjing 3
Naples 3
Nashville 3
Perugia 3
Raleigh 3
San Diego 3
Sassari 3
Spilimbergo 3
Tainan City 3
Torino 3
Venezia 3
Wawern 3
Amsterdam 2
Andover 2
Apo 2
Asyut 2
Bacoor 2
Bagnara Calabra 2
Biancavilla 2
Bogotá 2
Bologna 2
Brno 2
Casier 2
Cernusco sul Naviglio 2
Cesenatico 2
Chicago 2
Ciudad Real 2
Coimbra 2
Copenhagen 2
Totale 1.560
Nome #
Alveolar Epithelial Type II Cells 129
Radiological-pathological signatures of patients with COVID-19-related pneumomediastinum: is there a role for the Sonic hedgehog and Wnt5a pathways? 106
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO) 97
Low sensitivity of rapid tests detecting anti-CoV-2 IgG and IgM in health care workers’ serum for COVID-19 screening 85
Limited role for bronchoalveolar lavage to exclude Covid-19 after negative upper respiratory tract swabs: a multicenter study 84
The Treatment of Lung Involvement in Systemic Sclerosis 79
Chronic Thromboembolic Pulmonary Hypertension: An Update 71
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 71
Diagnostic Accuracy of Chest Digital Tomosynthesis in Patients Recovering after COVID-19 Pneumonia 69
High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients 65
Laser Speckle Contrast Analysis: Functional Evaluation of Microvascular Damage in Connective Tissue Diseases. Is There Evidence of Correlations With Organ Involvement, Such as Pulmonary Damage? 65
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia 64
The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung 62
Correlation between Potential Risk Factors and Pulmonary Embolism in Sarcoidosis Patients Timely Treated 61
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension 57
Valutazione dei fattori di rischio di embolia polmonare nei pazienti affetti da sarcoidosi 56
Epithelial-Mesenchymal Transition: A Major Pathogenic Driver in Idiopathic Pulmonary Fibrosis? 54
Monitoring respiratory mechanics by oscillometry in COVID-19 patients receiving non-invasive respiratory support 54
Chronic Thromboembolic Pulmonary Hypertension: An Observational Study 53
Evaluation of Correlations between Genetic Variants and High‐Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis 53
Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy 52
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 52
Caution When Comparing the Impact of Corticosteroids in COVID-19 52
An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients 51
Hematopoietic Stem Cell Transplantation in Late‐onset X‐linked Chronic Granulomatous Disease in a Female Carrier 50
Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF) 49
Monitoring the microcirculation in the diagnosis and follow-up of systemic sclerosis patients: Focus on pulmonary and peripheral vascular manifestations 48
High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose? 48
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat? 47
Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS 47
Severe COVID‐19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail? 45
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 44
Transbronchial lung cryobiopsy and pulmonary fibrosis: A never-ending story? 40
Different Methods to Improve the Monitoring of Noninvasive Respiratory Support of Patients with Severe Pneumonia/ARDS Due to COVID-19: An Update 39
Successful treatment of life-threatening mycobacteriosis using adjunctive gamma-interferon therapy with genetic analysis 36
Monitoring lung mechanics by oscillometry in COVID 19 ARDS receiving non-invasive ventilation: a pilot study 36
179 C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 33
What Role Does Trabecular Bone Score Play in Chronic Inflammatory Rheumatic Diseases? 33
Clinical Evaluation of the ButterfLife Device for Simultaneous Multiparameter Telemonitoring in Hospital and Home Settings 32
Host-Based Treatments for Severe COVID-19 30
Chronic Obstructive Pulmonary Disease definition: is it time to incorporate also the concept of lung regeneration's failure? 30
The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients 29
Risk factor of pulmonary embolism in sarcoidosis patients: a pilot study 28
Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 27
Higher, but Not Too High, Dose Is Only One Determinant of Corticosteroid Treatment Success in Severe COVID-19 24
Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria 23
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner? 22
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial 21
Correlation between Microvascular Damage and Internal Organ Involvement in Scleroderma: Focus on Lung Damage and Endothelial Dysfunction 21
Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy 21
Pulmonary Sarcoidosis and Immune Dysregulation: A Pilot Study on Possible Correlation 20
Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter-A Critical Review and Viewpoints 19
Biomarkers in Systemic Sclerosis: An Overview 19
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study) 19
Evaluation of chronic thromboembolic pulmonary hypertension: a pilot-study 17
Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study 17
Nailfold Capillaroscopy Analysis Can Add a New Perspective to Biomarker Research in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 12
Oscillometry Longitudinal Data on COVID-19 Acute Respiratory Syndrome Treated with Non-Invasive Respiratory Support 11
Evaluation of possible risk factor of pulmonary embolism in sarcoidosis patients 9
Cardiopulmonary exercise testing complements both spirometry and nuclear imaging for assessing sarcoidosis stage and for monitoring disease activity 9
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows 7
Vascular Endothelial Damage in COPD: Where Are We Now, Where Will We Go? 7
Trattamenti dell’ipertensione polmonare tromboembolica cronica (CTEPH): uno studio pilota 5
Totale 2.716
Categoria #
all - tutte 12.533
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.533


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021199 0 0 2 33 20 17 15 29 23 40 8 12
2021/2022489 43 12 28 57 39 13 32 14 72 35 41 103
2022/2023942 79 112 94 90 78 117 29 85 119 24 75 40
2023/20241.074 70 48 81 74 108 92 223 134 39 47 96 62
2024/202512 12 0 0 0 0 0 0 0 0 0 0 0
Totale 2.716